Summit Trail Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1698478
NEW YORK, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,922,373
-$408,681 QoQ
Shares Held
3,083
+2.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#520
of 1,322 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Summit Trail Advisors, LLC holds $31,541,707 across 29 Biotechnology names. REGN ranks #4 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
25,428 | $6,127,385 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,429 | $3,690,207 | |
| 3 | RPRX |
Royalty Pharma plc
|
39,362 | $2,207,027 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
3,083 | $1,922,373 | |
| 5 | MRNA |
Moderna, Inc.
|
24,030 | $1,682,820 | |
| 6 | TECH |
BIO-TECHNE Corp
|
22,807 | $1,611,314 | |
| 7 | INCY |
Incyte Corp
|
13,838 | $1,568,675 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
7,559 | $1,415,649 |
All Filings in REGN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,922,373 | 3,083 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,331,054 | 3,017 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,955,918 | 2,534 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,724,482 | 3,067 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,192,275 | 2,271 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,049,650 | 1,655 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $994,412 | 1,396 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $1,461,223 | 1,390 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,321,144 | 1,257 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,105,901 | 1,149 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $911,665 | 1,038 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $906,901 | 1,102 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $764,526 | 1,064 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $673,769 | 820 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $478,347 | 663 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $441,565 | 641 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $524,923 | 888 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $597,847 | 856 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||